Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists are injectable medications that mimic glucagon-like peptide-1, a hormone your gut naturally produces after eating. Clinical trials show these compounds reduce appetite and support sustainable weight loss when combined with lifestyle changes. PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A pharmacies.

What Is Actually in a GLP-1 Injection

A GLP-1 shot contains three main components: the active pharmaceutical ingredient (the receptor agonist itself), sterile water or saline as the carrier liquid, and preservatives that keep the medication stable. Semaglutide, one of the most studied GLP-1 compounds, is a modified version of the naturally occurring GLP-1 hormone, engineered to last longer in your bloodstream than your body's own version. The injectable form allows direct absorption into subcutaneous tissue, delivering consistent dosing without passing through your digestive system first.

Compounded versions from licensed 503A pharmacies contain the same active pharmaceutical ingredients as branded options but are prepared in smaller batches under strict quality control. PlexusDx partners exclusively with 503A compounders—never 503B facilities—ensuring pharmaceutical-grade preparation. Each dose maintains sterility and potency through proper storage and handling protocols that your healthcare provider will review with you before your first injection.

How GLP-1 Agonists Work in Your Body

When you inject a GLP-1 agonist, it travels through your bloodstream to bind with GLP-1 receptors in your brain, pancreas, and stomach. In your brain's appetite control centers, this activation produces a sustained signal of fullness, reducing cravings and portion sizes without willpower alone. Simultaneously, the medication slows how fast food leaves your stomach, keeping you satisfied longer after meals.

Beyond appetite suppression, GLP-1 agonists also improve how your pancreas releases insulin in response to meals, which helps normalize blood sugar levels. Research shows that semaglutide users experience reduced hemoglobin A1C levels even when weight loss alone wouldn't explain the improvement, indicating direct metabolic benefits. This multi-pathway mechanism is why these medications have become standard options for both weight management and type 2 diabetes care.

Semaglutide vs. Tirzepatide: Key Composition Differences

Semaglutide activates only GLP-1 receptors, making it a single-pathway agent that has been studied in millions of patients since its approval. Tirzepatide, a newer dual-agonist compound, activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously, potentially offering broader metabolic effects. Both medications are available through PlexusDx in injectable and oral forms, with tirzepatide injection starting at $249 per month.

The choice between them depends on your individual genetics, metabolism, and health goals—which is why PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first treatment month. This test maps 14 metabolic pathways and 49 key peptides to reveal how your body responds to GLP-1 versus GIP pathway activation. Your genetic profile at sites like GIPR rs1800437 and GLP1R rs6923761 may influence whether semaglutide or tirzepatide offers superior results for your weight loss journey.

Why Composition Matters for Safety and Effectiveness

The pharmaceutical composition of your GLP-1 medication directly affects how your body absorbs, distributes, and metabolizes it. Compounded formulations from 503A pharmacies must meet the same USP (United States Pharmacopeia) standards as large-scale manufacturers, ensuring purity and concentration accuracy. PlexusDx works with licensed compounders who test every batch for sterility, potency, and absence of endotoxins before dispensing to patients.

Understanding composition also helps you anticipate how quickly you'll feel effects and how your body may respond over time. Injectable semaglutide reaches peak levels within 1-3 days and remains active for about a week, which is why dosing typically occurs once weekly. Side effects like mild nausea tend to decrease as your body adapts to the medication's presence, and knowing the exact formulation your provider selected helps you distinguish expected adjustment from genuine adverse reactions that warrant medical attention.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is there a difference between branded GLP-1 shots and PlexusDx compounded versions?

Both contain identical active pharmaceutical ingredients, but PlexusDx compounded semaglutide from licensed 503A pharmacies costs significantly less—starting at $149 monthly versus $900–$1,300 for branded versions—while maintaining the same pharmaceutical standards.

Can I be allergic to anything in a GLP-1 injection?

True allergies to semaglutide or tirzepatide are rare, but some people react to preservatives or the injection technique itself. If you have a history of medullary thyroid cancer or multiple endocrine neoplasia type 2, these medications are contraindicated. Discuss any allergies with your PlexusDx provider before starting treatment.

How does your dose change if GLP-1 isn't working well enough?

Your PlexusDx provider can gradually increase your dose over weeks or months based on your response and tolerance. The key difference with PlexusDx pricing: your dose may need to go up, but your price won't—you pay a flat monthly rate regardless of dose level, starting at $149 for semaglutide injection.

What makes the Precision Peptide Genetic Test different from pharmacogenomic testing?

PlexusDx's Precision Peptide test examines your genetic variants in peptide pathways—like FTO rs9939609 and MC4R rs17782313—that influence appetite regulation and metabolic response, rather than how your liver metabolizes drugs.

Does PlexusDx work with insurance, and are these medications HSA/FSA eligible?

PlexusDx requires no insurance, no membership fees, and serves all 50 states with transparent flat-rate pricing. Compounded semaglutide and tirzepatide are HSA/FSA eligible, so you may use pre-tax dollars to cover your monthly medication cost.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves